Commentary

Niacin: Not Dead Yet, but on Life Support

Author and Disclosure Information

Let me begin by confirming unequivocally that I’ve long been one of the strongest and loudest advocates of using niacin in the treatment of dyslipidemia. I’ve been taking large doses of immediate-release niacin for more than 20 years, to the current tune of a whopping 5 grams a day. It’s been nearly 2 decades since I penned a muscular editorial for the Archives of Family Practice entitled, “Why Aren’t We Using More Niacin?” I’ve written similarly-haranguing editorials in this very journal you hold in your hands, aggressively advocating more widespread use of this seemingly-miraculous lipid-lowering therapy.


 

Recommended Reading

Doubling Up on New Hypertension
Federal Practitioner
Clinical Pharmacy Specialists Help Achieve an LDL-Cholesterol Performance Goal in Veterans With Diabetes
Federal Practitioner
Probing a Probe's Efficacy in Evaluating Cardiovascular Health
Federal Practitioner
Smoking and Clopidogrel Response
Federal Practitioner
Statins Plus Antiplatelet Treatment for VTE
Federal Practitioner
Update on Getting a Handle on High Cholesterol
Federal Practitioner
Bedside Assessment Skills Still Important
Federal Practitioner
Esomeprazole and Famotidine Work Well With Clopidogrel
Federal Practitioner
Women Missing Out on Cholesterol Screening
Federal Practitioner
A Brighter Prognosis in Nonalcoholic Fatty Liver Disease
Federal Practitioner